The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...

ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...

In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models to ...

The Bulls N’ Bears ASX Runner of the Week is… Hydrix Ltd, which locked in a $2.5million deal to develop SynCardia’s next-gen ...

Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...

The Zika virus epidemic that began in Brazil in 2015 and quickly spread to other countries caused an unprecedented flood of ...

You can find the first volume of this Research Topic here.Scrub Typhus is a vector-borne zoonotic disease, mostly prevalent ...

Simultaneously, a substantial legal threat has emerged. Bayer AG has filed suit against BioNTech, its partner Pfizer, and competitor Moderna. The litigation centers on patents originally developed by ...

In a surprising discovery, University of New Mexico researchers have found that OTULIN – an enzyme that helps regulate the immune system – also drives ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

S&P 500 gains derive from few stocks. Learn ETF vs. stock-picking tradeoffs, timing risks, and theme investing ...

US stocks closed mixed on Thursday as investors rotated out of tech as they took in fresh labor market data and grappled with ...